Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep 19;13(18):5538.
doi: 10.3390/jcm13185538.

Endoscopic Submucosal Dissection for Early Gastric Cancer Exceeding Expanded Criteria-Long-Term Outcomes from the German ESD Registry

Affiliations

Endoscopic Submucosal Dissection for Early Gastric Cancer Exceeding Expanded Criteria-Long-Term Outcomes from the German ESD Registry

Kathrin Riedl et al. J Clin Med. .

Abstract

Background and aims: Endoscopic submucosal dissection (ESD) has become a standard treatment for early gastric cancer (EGC), often fulfilling guideline criteria (GC) or expanded criteria (EC). When lesions exceed the EC, surgical resection is recommended. However, a subgroup of these patients are not treated surgically. The aim of this study was to investigate the long-term follow-up of patients after ESD for EGC outside the EC (out of indication; OI). Methods: Patients who were included in the prospective German ESD registry were analyzed when ESD was performed for EGC. Patients were stratified in three groups according to histopathological features (GC, EC and OI). The results were evaluated in terms of patient characteristics, procedure characteristics and follow-up data. Results: Over a 48-month period, 195 patients from 14 German centers were included. In total, 71 lesions (36.4%) met the guideline criteria, 70 lesions (35.9%) corresponded to the expanded criteria and 54 lesions (27.7%) turned out to be OI. The R0 resection rate was significantly higher for the GC and EC groups than for the OI group (94.4% vs. 84.3% vs. 55.6%, p < 0.001). Additional surgery was not performed in 72% (39/54) of patients in the OI group. During a mean follow-up of 37 months, overall survival showed no significant difference between the EC and OI groups when endoscopic follow-up was performed without additional surgery (p = 0.064). Conclusions: The results show that a good long-term survival can be achieved after ESD for patients with OI lesions without additional surgery. The treatment decision has to be made on an individual basis, taking the patient's comorbidities and the risk of surgical resection into account.

Keywords: early gastric cancer; endoscopic resection; endoscopic submucosal dissection; endoscopy; expanded criteria; guideline criteria.

PubMed Disclaimer

Conflict of interest statement

Messmann: Olympus, Satisfai (grants), Falk Pharma, Olympus, Norgine, IPSEN, medupdate, Erbe (speakers fees), Olympus, Ambu, Boston Scientific, Covidien, Takeda (consultation fees); Rempel: Olympus, Falk (lecture fees, tutoring, consultancy); Steinbrück: Olympus, Falk (lecture fees and travel grants); Allgaier: Olympus, Falk (lecture fees); Dumoulin: Olympus (lecture fees, tutoring, consultancy). The other authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Patient inclusion. ESD: endoscopic submucosal dissection; EGC: early gastric cancer; LGD: low-grade dysplasia; HGD: high-grade dysplasia.
Figure 2
Figure 2
Included EGC: grouping according to histopathological assessment. EGC: early gastric cancer.
Figure 3
Figure 3
Follow-up of patients after endoscopic submucosal dissection of early gastric cancers. VM: vertical margin; HM: horizontal margin; ESD: endoscopic submucosal dissection; FTRD: full-thickness-resection; LNM: lymph node metastasis.
Figure 4
Figure 4
Overall survival for the different patient groups (p = 0.064 for the comparison of EC group vs. OI group).

References

    1. Japanese Gastric Cancer Association Japanese Gastric Cancer Treatment Guidelines 2021 (6th edition) Gastric Cancer. 2023;26:1–25. doi: 10.1007/s10120-022-01331-8. - DOI - PMC - PubMed
    1. Gotoda T., Yanagisawa A., Sasako M., Ono H., Nakanishi Y., Shimoda T., Kato Y. Incidence of lymph node metastasis from early gastric cancer: Estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–225. doi: 10.1007/PL00011720. - DOI - PubMed
    1. Jeon H.K., Lee S.J., Kim G.H., Park D.Y., Lee B.E., Song G.A. Endoscopic submucosal dissection for undifferentiated-type early gastric cancer: Short- and long-term outcomes. Surg. Endosc. 2018;32:1963–1970. doi: 10.1007/s00464-017-5892-3. - DOI - PubMed
    1. Huh C.W., Ma D.W., Kim B.W., Kim J.S., Lee S.J. Endoscopic Submucosal Dissection versus Surgery for Undifferentiated-Type Early Gastric Cancer: A Systematic Review and Meta-Analysis. Clin. Endosc. 2021;54:202–210. doi: 10.5946/ce.2020.121. - DOI - PMC - PubMed
    1. Hirai Y., Abe S., Makiguchi M.E., Sekiguchi M., Nonaka S., Suzuki H., Yoshinaga S., Saito Y. Endoscopic Resection of Undifferentiated Early Gastric Cancer. J. Gastric Cancer. 2023;23:146–158. doi: 10.5230/jgc.2023.23.e13. - DOI - PMC - PubMed

LinkOut - more resources